Authors:
SION C
AVESANI V
GARRINO MG
DELMEE M
GLUPCZYNSKI Y
Citation: C. Sion et al., NOSOCOMIAL OUTBREAKS OF SALMONELLA-ENTERITIDIS IN A UNIVERSITY HOSPITAL, Infection control and hospital epidemiology, 19(8), 1998, pp. 610-610
Authors:
CADRANEL S
CORVAGLIA L
BONTEMS P
DEPREZ C
GLUPCZYNSKI Y
VANRIET A
KEPPENS E
Citation: S. Cadranel et al., DETECTION OF HELICOBACTER-PYLORI INFECTION IN CHILDREN WITH A STANDARDIZED AND SIMPLIFIED C-13-UREA BREATH TEST, Journal of pediatric gastroenterology and nutrition, 27(3), 1998, pp. 275-280
Citation: Y. Glupczynski, MICROBIOLOGICAL AND SEROLOGICAL DIAGNOSTIC-TESTS FOR HELICOBACTER-PYLORI - AN OVERVIEW, British Medical Bulletin, 54(1), 1998, pp. 175-186
Citation: Y. Glupczynski, MICROBIOLOGICAL AND SEROLOGICAL DIAGNOSTIC-TESTS FOR HELICOBACTER-PYLORI - AN OVERVIEW, Acta Gastro-Enterologica Belgica, 61(3), 1998, pp. 321-326
Citation: Y. Glupczynski, ANTIMICROBIAL RESISTANCE IN HELICOBACTER-PYLORI - A GLOBAL OVERVIEW, Acta Gastro-Enterologica Belgica, 61(3), 1998, pp. 357-366
Authors:
VANHOOF R
CARPENTIER M
GLUPCZYNSKI Y
GORDTS B
MAGERMAN K
MANS Y
NYSSEN HJ
SIMON A
SURMONT I
VANDEVYVERE M
VANLANDUYT H
VANNIMMEN L
VANNOYEN R
Citation: R. Vanhoof et al., SURVEILLANCE OF PNEUMOCOCCAL RESISTANCE IN BELGIUM DURING WINTER 1996-1997, Acta Clinica Belgica, 53(4), 1998, pp. 275-281
Authors:
GLUPCZYNSKI Y
DELMEE M
GOOSSENS H
STRUELENS M
Citation: Y. Glupczynski et al., A MULTICENTER SURVEY OF ANTIMICROBIAL RESISTANCE IN GRAM-NEGATIVE ISOLATES FROM BELGIAN INTENSIVE-CARE UNITS IN 1994-1995, Acta Clinica Belgica, 53(1), 1998, pp. 28-38
Authors:
MILLER GH
SABATELLI FJ
HARE RS
GLUPCZYNSKI Y
MACKEY P
SHLAES D
SHIMIZU K
SHAW KJ
BAUERNFEIND A
SCHWEIGHART S
SHANNON K
PATZER J
MOLINARI G
SCHITO GC
GOMEZLUS R
GOMEZLUS S
FERREIRA H
SOUSA JC
VAZ MJM
COLLATZ E
BISMUTH R
LAMBERT T
COURVALIN P
MINOZZI C
KLUGMAN K
BILGERI Y
GIAMARELLOU H
PETRIKKOS G
AKALIN H
GUR D
WOLOJ M
ROSSI A
CASELLAS J
TOKUMOTO M
COUTO E
JULIET C
PINTO ME
ZEMELMAN R
PEDREIRA W
FERNANDEZ M
LEAL I
GUZMAN M
MURILLO J
ISTURIZ P
MERENTES A
BREMNER A
HO B
MAYER K
ELLAL J
FU W
ZHU D
DORNBUSCH K
GORANSSON E
Citation: Gh. Miller et al., THE MOST FREQUENT AMINOGLYCOSIDE RESISTANCE MECHANISMS - CHANGES WITHTIME AND GEOGRAPHIC AREA - A REFLECTION OF AMINOGLYCOSIDE USAGE PATTERNS, Clinical infectious diseases, 24, 1997, pp. 46-62
Citation: Y. Glupczynski et Jm. Devaster, ROLE OF GASTRIC-MUCOSAL CYTOKINES IN THE IMMUNOPATHOGENESIS OF HELICOBACTER-PYLORI INFECTION - NEW HYPOTHESES BUT STILL FEW CERTITUDES, European journal of gastroenterology & hepatology, 9(5), 1997, pp. 447-450
Authors:
MALFERTHEINER P
MEGRAUD F
OMORAIN C
BELL D
BIANCHI PG
DELTENRE M
FORMAN D
GASBARRINI G
JAUP B
MISIEWICZ G
PAJARES J
QUINA M
RAUWS E
ANDERSEN L
ARENAS MI
BAZZOLI F
BERSTAD A
BIANCHI P
BIRKNER B
BRUN J
BUCKLEY M
BURES J
BUTRUK E
CADRANEL S
CASAS RJ
CASPARY F
COTTRILL M
CULHANE A
DEKOSTER E
DITE P
FARKKILA M
FUJIOKA T
FUKUDA T
GLUPCZYNSKI Y
HIRSCHL A
HUNT R
JOHANNESSEN T
KREJS G
LABENZ J
LAMERS C
LIND T
MCCOLL K
NUESCH H
ODONOGHUE D
OFFER G
PEURA D
POMBAL R
POUNDER R
PRETOLANI P
ROKKAS T
ROMAOZINHO J
RUNE S
SANDELOWSKY H
SEIFERT B
SHIMOYAMA T
SJOLUND K
STOCKBRUGGER R
THOMSON A
UBALDI E
UNGE P
VANCUTSEM E
WADSTROM T
WEBER J
SIPPONEN P
PRICE A
Citation: P. Malfertheiner et al., CURRENT EUROPEAN CONCEPTS IN THE MANAGEMENT OF HELICOBACTER-PYLORI INFECTION - THE MAASTRICHT CONSENSUS REPORT, Gut, 41(1), 1997, pp. 8-13
Authors:
GLUPCZYNSKI Y
VANDENBORRE C
GOUTIER S
BURETTE A
DEVASTER JM
BUTZLER JP
Citation: Y. Glupczynski et al., EVALUATION OF METRONIDAZOLE AND CLARITHROMYCIN SCREENING AGAR PLATES FOR IN-VITRO SUSCEPTIBILITY TESTING OF HELICOBACTER-PYLORI, Gut, 41, 1997, pp. 2-2
Authors:
GLUPCZYNSKI Y
VANDENBORRE C
GOUTIER S
BURETTE A
DEVASTER JM
BUTZLER JP
Citation: Y. Glupczynski et al., EVALUATION OF METRONIDAZOLE AND CLARITHROMYCIN SCREENING AGAR PLATES FOR IN-VITRO SUSCEPTIBILITY TESTING OF HELICOBACTER-PYLORI, Gut, 41, 1997, pp. 71-71
Authors:
GLUPCZYNSKI Y
ECTORS N
BURETTE A
NOE M
LARUELLE N
VANDENHOVEN G
Citation: Y. Glupczynski et al., METHODOLOGICAL LESSONS LEARNED FROM A MULTICENTER TRIAL OF HELICOBACTER-PYLORI INFECTION USING CENTRALIZED LABORATORY FACILITIES, Gut, 41, 1997, pp. 71-71
Authors:
GLUPCZYNSKI Y
LEFEBVRE R
BURETTE A
MANSY F
LAGE A
FAUCONNIER A
GODFROID E
Citation: Y. Glupczynski et al., EVALUATION OF PYLORI-PROB(R), A NEW COMMERCIALLY AVAILABLE PCR ASSAY,FOR THE POSTTREATMENT DIAGNOSIS OF HELICOBACTER-PYLORI INFECTION, Gut, 41, 1997, pp. 74-75
Authors:
BURETTE A
RAMDANI B
DEPREZ C
GLUPCZYNSKI Y
Citation: A. Burette et al., 7 OR 12 DAYS TRIPLE THERAPIES COMBINING OMEPRAZOLE WITH AMOXICILLIN AND CLARITHROMYCIN TO CURE HELICOBACTER-PYLORI, Gastroenterology, 112(4), 1997, pp. 80-80
Authors:
BURETTE A
LAMY V
LIGNY G
CABOOTER M
RAMDANI B
ECTORS N
GLUPCZYNSKI Y
Citation: A. Burette et al., DUAL OR TRIPLE THERAPY COMBINING OMEPRAZOLE WITH AMOXICILLIN AND OR CLARITHROMYCIN FOR HELICOBACTER-PYLORI INFECTION/, Gastroenterology, 112(4), 1997, pp. 80-80
Authors:
DEBONGNIE JC
BURETTE A
GLUPCZYNSKI Y
DEPREZ C
DEKONINCK X
DONNAY M
Citation: Jc. Debongnie et al., HELICOBACTER-PYLORI AND GASTRIC-CANCER - AN ENDOSCOPIC SERIES, Acta Gastro-Enterologica Belgica, 60(3), 1997, pp. 189-191
Citation: Y. Glupczynski, PROLONGED GASTRIC-ACID SUPPRESSION THERAPY - A SIGNIFICANT RISK FACTOR FOR LISTERIA-MONOCYTOGENES INFECTION, European journal of gastroenterology & hepatology, 8(11), 1996, pp. 1063-1066
Authors:
DEBONGNIE JC
BURETTE A
GLUPCZYNSKI Y
DEPREZ C
DEKONINCK X
DONNAY M
Citation: Jc. Debongnie et al., GASTRIC-ULCER AND HELICOBACTER-PYLORI - C LINICAL, ENDOSCOPIC AND HISTOLOGIC CHARACTERISTICS, Gastroenterologie clinique et biologique, 20(1), 1996, pp. 15-19
Authors:
LAGE AP
FAUCONNIER A
BURETTE A
GLUPCZYNSKI Y
BOLLEN A
GODFROID E
Citation: Ap. Lage et al., RAPID COLORIMETRIC HYBRIDIZATION ASSAY FOR DETECTING AMPLIFIED HELICOBACTER-PYLORI DNA IN GASTRIC BIOPSY SPECIMENS, Journal of clinical microbiology, 34(3), 1996, pp. 530-533
Authors:
BURETTE A
RAMDANI B
GLUPCZYNSKI Y
DEPREZ C
Citation: A. Burette et al., SENSITIVITY AND SPECIFICITY OF THE DIFFERENT PER-ENDOSCOPIC DIAGNOSTIC METHODS FOR POSTTREATMENT DETECTION OF HELICOBACTER-PYLORI, Gastroenterology, 110(4), 1996, pp. 72-72
Authors:
VANHOOF R
CARPENTIER M
GLUPCZYNSKI Y
GORDTS B
MAGERMAN K
NYSSEN HJ
SIMON A
VANDEVYVERE M
VANLANDUYT H
VANNIMMEN L
VANNOYEN R
Citation: R. Vanhoof et al., IN-VITRO SUSCEPTIBILITIES OF 176 CLINICAL ISOLATES OF STREPTOCOCCUS-PNEUMONIAE TO 11 BETA-LACTAMS, ERYTHROMYCIN, AND TETRACYCLINE, Acta Clinica Belgica, 51(6), 1996, pp. 377-385
Authors:
DELMEE M
CARPENTIER M
GLUPCZYNSKI Y
GORDTS B
MAGERMAN K
SIMON A
SURMONT I
VANDEVYVERE M
VANLANDUYT H
VANNIMMEN L
VANNOYEN R
Citation: M. Delmee et al., IN-VITRO SUSCEPTIBILITIES OF 180 CLINICAL ISOLATES OF HAEMOPHILUS-INFLUENZAE TO AMPICILLIN, AMOXYCILLIN CLAVULANATE, CEFACLOR, CEFUROXIME, CEFOTAXIME, CLARITHROMYCIN, AND AZITHROMYCIN/, Acta Clinica Belgica, 51(4), 1996, pp. 237-243
Authors:
PIERARD D
DEMEYER A
ROSSEEL P
VANCAUWENBERGH M
STRUELENS MJ
DELMEE M
GOOSSENS H
CLAEYS G
GLUPCZYNSKI Y
VERBIST L
MELIN P
LAUWERS S
Citation: D. Pierard et al., IN-VITRO ACTIVITY OF AMOXYCILLIN CLAVULANATE AND TICARCILLIN/CLAVULANATE COMPARED WITH THAT OF OTHER ANTIBIOTICS AGAINST ANAEROBIC-BACTERIA- COMPARISON WITH THE RESULTS OF THE 1987 SURVEY/, Acta Clinica Belgica, 51(2), 1996, pp. 70-79